Abstract
In most patients, coronavirus disease-2019 (COVID-19) causes minor respiratory symptoms or even no symptoms. SARS-CoV-2 infection can also cause extrapulmonary manifestations and complications. COVID-19 is more severe and fatal among patients with pre-existing cardiovascular risk factors or diseases. Increases in cardiac troponin (cTn) are indicative of myocardial injury and frequently found in patients with COVID-19. The Chinese Center for Disease Control and Prevention published a survey demonstrating that among patients diagnosed with COVID-19, 13% had hypertension, 5% had diabetes mellitus, [...]
Highlights
In this issue of the International Journal of Cardiovascular Sciences, Rocha et al,4 studied 192 patients admitted with COVID-19 in a quaternary care cardiac hospital in Rio de Janeiro, Brazil
The main limitations of the study are a sample from a single Brazilian metropolitan region and a short follow-up period. These limitations do not invalidate the main message of the study: the measurement of cardiac troponin at hospital admission may be useful for identification of high-risk patients infected by SARS-CoV-2
Patients with COVID-19 have several conditions that may be associated with myocardial injury such as myocarditis, stress cardiomyopathy, acute heart failure, pulmonary embolism, critical illness, and sepsis.[2]
Summary
In this issue of the International Journal of Cardiovascular Sciences, Rocha et al ,4 studied 192 patients admitted with COVID-19 in a quaternary care cardiac hospital in Rio de Janeiro, Brazil. Cardiovascular Diseases/complications; COVID-19/ complications; SARS-CoV-2; Risk Factors; Hypertension; Diabetes Mellitus; Troponin I; Hospitalization; Mortality.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
